These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9115157

  • 1. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone.
    Garnero P, Christgau S, Delmas PD.
    Bone; 2001 May; 28(5):461-4. PubMed ID: 11344044
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ, Gunasekera RD.
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
    Ryan PJ, Sherry M, Gibson T, Fogelman I.
    Br J Rheumatol; 1992 Feb; 31(2):97-101. PubMed ID: 1371084
    [Abstract] [Full Text] [Related]

  • 10. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti D, Gennari L, Martini G, Valleggi F, De Paola V, Avanzati A, Nuti R.
    J Bone Miner Res; 2007 Oct; 22(10):1510-7. PubMed ID: 17605632
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1989 Jan 21; 119(3):71-4. PubMed ID: 2711157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL.
    Br Med J (Clin Res Ed); 1987 Nov 21; 295(6609):1301-5. PubMed ID: 3120987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone.
    Bockman RS, Wilhelm F, Siris E, Singer F, Chausmer A, Bitton R, Kotler J, Bosco BJ, Eyre DR, Levenson D.
    J Clin Endocrinol Metab; 1995 Feb 21; 80(2):595-602. PubMed ID: 7852526
    [Abstract] [Full Text] [Related]

  • 19. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Hamdy NA, Papapoulos SE, Colwell A, Eastell R, Russell RG.
    Bone Miner; 1993 Jul 21; 22(1):1-8. PubMed ID: 8219934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.